Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 106
Titolo Tipologia Data di pubblicazione Autori File
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 02 - Intervento a convegno 2024 Crippa, VFontana, DCivettini, IMologni, LPiazza, RGambacorti Passerini, CRamazzotti, D
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 01 - Articolo su rivista 2024 Villa, MatteoMalighetti, FedericaManfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 01 - Articolo su rivista 2023 Aroldi, AMauri, MRamazzotti, DVilla, MMalighetti, FCrippa, VCocito, FBorella, CBossi, ESteidl, CScollo, CMologni, LPiazza, RGambacorti Passerini, C +
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 01 - Articolo su rivista 2023 Malighetti, FedericaMauri, MarioVilla, MatteoManghisi, BeatriceInzoli, ElenaRindone, GiovanniCivettini, IvanGuglielmana, VeronicaRamazzotti, DanieleBombelli, SilviaPerego, RobertoPiazza, RoccoMologni, LucaGambacorti-Passerini, Carlo +
Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition 01 - Articolo su rivista 2023 Massimino, LucaBrusco, SimoneBarone, CristianaD'Aliberti, DeborahSpinelli, SilviaMologni, LucaAzzoni, EmanuelePiazza, Rocco +
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 01 - Articolo su rivista 2023 Nicoletta CordaniLuca MologniRocco PiazzaPietro TettamantiMario MauriMatteo VillaFederica MalighettiCamillo Di BellaMaria Grazia CerritoGuido CavalettiMarialuisa LavitranoMarina Elena Cazzaniga +
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR 01 - Articolo su rivista 2023 Crippa, ValentinaMologni, Luca +
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 01 - Articolo su rivista 2023 Fontana, DCrespiatico, ICrippa, VMalighetti, FVilla, MAngaroni, FAroldi, AAntoniotti, MCaravagna, GPiazza, RGraudenzi, AMologni, LRamazzotti, D +
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma 01 - Articolo su rivista 2023 Mastini C.D’Aliberti D.Mologni L.Piazza R.Gambacorti Passerini C. +
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 01 - Articolo su rivista 2023 Crippa, ValentinaMalighetti, FedericaVilla, MatteoGraudenzi, AlexPiazza, RoccoMologni, LucaRamazzotti, Daniele
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 01 - Articolo su rivista 2023 Massimino, LucaPirola, AlessandraMologni, LucaPiazza, Rocco Giovanni +
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 02 - Intervento a convegno 2023 Nicoletta CordaniLuca MologniRocco PiazzaCamillo Di BellaMaria Grazia CerritoMatteo VillaGuido CavalettiMarialuisa LavitranoMarina Elena Cazzaniga +
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 01 - Articolo su rivista 2023 Nicoletta CordaniGiuseppe PagliaRamona MeantiMaria Grazia CerritoChiara VillaMario MauriLuca MologniAntonio TorselloMarina Elena Cazzaniga +
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 02 - Intervento a convegno 2022 Fontana, DCrippa, VBassi, GD'Aliberti, DMauri, MSpinelli, SMastini, CBombelli, SCivettini, IGuglielmana, VRamazzotti, DMologni, LPiazza, RGambacorti Passerini, C +
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 02 - Intervento a convegno 2022 Villa, MMalighetti, FArosio, GManfroni, CFontana, DCordani, NMeneveri, RZambon, APiazza, RPagni, FCortinovis, DMologni, L +
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase 01 - Articolo su rivista 2022 Mologni, LucaCeccon, MonicaViltadi, MichelaVece, VitoGambacorti-Passerini, Carlo +
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 01 - Articolo su rivista 2022 Steidl, CarolinaAroldi, AndreaMologni, LucaCrespiatico, IlariaFontana, DilettaMastini, CristinaBorin, LorenzaPiazza, RoccoGambacorti-Passerini, Carlo +
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 01 - Articolo su rivista 2022 Mologni L.Gambacorti Passerini C. +
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase 01 - Articolo su rivista 2022 Mologni, LucaOrsato, AlexandreCeccon, MonicaViltadi, MichelaVece, VitoGambacorti-Passerini, Carlo +
Mostrati risultati da 1 a 20 di 106
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile